Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received 1 out of 2 of the shots back in 2020, and never got the 2nd one; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 02 November 2020). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received 1 out of 2 of the shots back in 2020, and never got the 2nd one). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 09-MAY-2025 The registered pharmacist reported that one of the patients received 1 out of 2 of the Shingrix shots back in 2020 on 02nd November 2020, and she never got the 2nd one which led to incomplete course of vaccination. The Vaccine Administration Facility is the same as Primary Reporter.